A Comprehensive Approach to Understanding, Evaluating & Planning for the Commercialization of Transformative Cell & Gene Therapies to Gain Insights into the Challenges Faced, Forming a Robust Foundation for Strategic Decisions
Time: 1:01 pm
day: Pre-Conference Workshop Day
Details:
This session will help you understand, evaluate and plan for the commercialization of cell and gene therapies in the healthcare landscape. It encompasses financial considerations, patient outcome monitoring, commercial adoption, addressing challenges, ensuring patient coverage, and strategizing for future therapy delivery. This session will dive into the ‘Three Ps’ of early stages of gene therapy commercialization.
Join this workshop to:
- Review the patient journey, exploring the inpatient vs outpatient considerations and various patient services and treatment centers
- Unravel the nuances of the product journey, diving into product mapping to drive stakeholder engagement, manufacturing considerations and payer tactics
- Gain insights into the evolving payment journey, addressing HCPCS challenges and patient involvement in the coding journey
